Stockholm Stock Exchange | Mid Cap
Camurus
+20.53%
Latest
+16.67%
3 months
CarnegieJefferiesNordea MarketsHandelsbankenDNB MarketsDNB

Price Targets

Latest price targets per analyst.

AnalystPrice TargetDateUpside
Carnegie229 SEKMay 13
+20.53%
Jefferies205 SEKApr 4
Nordea Markets231 SEKApr 1
Handelsbanken235 SEKDec -21
DNB Markets275 SEKNov -21
DNB300 SEKJul -21

About The Company

Camurus AB is a Swedish research-based pharmaceutical and biotechnology company specialising in the commercialization of medicines for treating serious and chronic diseases.
Wikipedia